Similar articles for PMID: 30308088

Year	Number of Results
1982	1
1990	1
1991	1
1995	2
2000	2
2004	1
2005	6
2006	4
2007	6
2009	6
2010	7
2011	6
2012	7
2013	3
2014	8
2015	8
2016	3
2017	5
2018	9
2019	8
2022	1
2024	0

1

Update on pharmacologically-relevant vitamin D analogues.

Jones G, Kaufmann M. Jones G, et al. Br J Clin Pharmacol. 2019 Jun;85(6):1095-1102. doi: 10.1111/bcp.13781. Epub 2018 Nov 22. Br J Clin Pharmacol. 2019. PMID: 30308088 Free PMC article. Review.

2

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.

DeLuca HF, Bedale W, Binkley N, Gallagher JC, Bolognese M, Peacock M, Aloia J, Clagett-Dame M, Plum L. DeLuca HF, et al. J Bone Miner Res. 2011 Mar;26(3):538-45. doi: 10.1002/jbmr.256. J Bone Miner Res. 2011. PMID: 20890933 Free article. Clinical Trial.

3

Interventions for metabolic bone disease in children with chronic kidney disease.

Hahn D, Hodson EM, Craig JC. Hahn D, et al. Cochrane Database Syst Rev. 2015 Nov 12;2015(11):CD008327. doi: 10.1002/14651858.CD008327.pub2. Cochrane Database Syst Rev. 2015. PMID: 26561037 Free PMC article. Review.

4

Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D₃ analogues.

Szybinski M, Sektas K, Sicinski RR, Plum LA, Frelek J, DeLuca HF. Szybinski M, et al. J Steroid Biochem Mol Biol. 2017 Jul;171:144-154. doi: 10.1016/j.jsbmb.2017.03.006. Epub 2017 Mar 8. J Steroid Biochem Mol Biol. 2017. PMID: 28285018

5

Metabolites and analogues of vitamin D. Which for what?

Haussler MR, Cordy PE. Haussler MR, et al. JAMA. 1982 Feb 12;247(6):841-4. JAMA. 1982. PMID: 6895767

6

Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.

Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF. Slatopolsky E, et al. J Bone Miner Res. 2007 May;22(5):686-94. doi: 10.1359/jbmr.070202. J Bone Miner Res. 2007. PMID: 17444814 Free article.

7

Vitamin D supplementation for cystic fibrosis.

Ferguson JH, Chang AB. Ferguson JH, et al. Cochrane Database Syst Rev. 2014 May 14;(5):CD007298. doi: 10.1002/14651858.CD007298.pub4. Cochrane Database Syst Rev. 2014. PMID: 24823922 Review.

8

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.

Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW. Sprague SM, et al. Am J Nephrol. 2016;44(4):316-325. doi: 10.1159/000450766. Epub 2016 Sep 28. Am J Nephrol. 2016. PMID: 27676085 Clinical Trial.

9

Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.

Minisola S, Cianferotti L, Biondi P, Cipriani C, Fossi C, Franceschelli F, Giusti F, Leoncini G, Pepe J, Bischoff-Ferrari HA, Brandi ML. Minisola S, et al. Osteoporos Int. 2017 Nov;28(11):3239-3249. doi: 10.1007/s00198-017-4180-3. Epub 2017 Aug 16. Osteoporos Int. 2017. PMID: 28815282 Clinical Trial.

10

Heterogeneity in osteosarcoma cell lines and the biological effects of the chemical structure of 25-hydroxyvitamin D₃ and 1 a,25 dihydroxyvitamin D₃.

Dokos C, Groll AH. Dokos C, et al. J Orthop Res. 2012 Dec;30(12):2052; author reply 2052-3. doi: 10.1002/jor.22155. Epub 2012 May 31. J Orthop Res. 2012. PMID: 22653562 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year